Results 121 to 130 of about 36,741 (290)

Predictors of glycemic control with imeglimin for type 2 diabetes: Results of machine learning analyses using clinical trial data

Journal of Diabetes Investigation, EarlyView.
Identifying patient characteristics predictive of treatment response is crucial for optimizing type 2 diabetes outcomes. Using data from three phase 2/3 imeglimin trials in Japan, this analysis applied machine learning to determine characteristics associated with HbA1c improvement.
Katsuhiko Hagi, Kazumasa Yoshida, Hirotaka Watada, Kohei Kaku, Kohjiro Ueki   +4 more
wiley   +1 more source

Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database

ClinicoEconomics and Outcomes Research, 2017
Silvio Mazzi,1 Roberto Ravasio,1 Gabriele Forlani,2 Giacomo Veronese,2 Andrea Fabbri,3 Giulio Marchesini2 1Department of Health Economics, Health Publishing & Services Srl, Milan, 2Unit of Metabolic Diseases and Clinical Dietetics, “Alma Mater
Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G   +5 more
doaj  

Effective and Safe Glycemic Control in Patients with Diabetes Mellitus Type 2 when Using Fixed Combination of Oral Hypoglycemic Agents

, 2013
V.І. Pankiv
openalex   +2 more sources

Advances in insulin pump systems lead to stepwise improvements in treatment satisfaction in people with type 1 diabetes: A single‐center retrospective study

Journal of Diabetes Investigation, EarlyView.
Transition from the MiniMed™ 770G HCL to the 780G AHCL significantly improved treatment satisfaction in participants with type 1 diabetes, exceeding the benefits during the earlier upgrade from the 640G PLGM to the 770G HCL. ABSTRACT Introduction Transition from the MiniMed™ 770G hybrid closed loop (HCL) to the MiniMed™ 780G advanced hybrid closed loop
Naoya Shimizu, Nozomi Ishimoto, Umeko Sakamoto, Mai Taneda, Akinori Hayashi, Takeshi Miyatsuka   +5 more
wiley   +1 more source

Effects of oral hypoglycemic agents, gliclazide and tolbutamide, on the cardiovascular system

, 1978
Hiroshi Maekawa, Junnosuke Yamamoto, Yoshiko Kato, Atsushi Sekiya   +3 more
openalex   +2 more sources

Impact of diabetes mellitus and grip strength on postoperative outcomes in older patients undergoing cancer surgery: A single‐center retrospective cohort study

Journal of Diabetes Investigation, EarlyView.
ABSTRACT Aims/Introduction Diabetes mellitus (DM) increases postoperative risks and may worsen physical function through muscle loss. Patients undergoing malignancies surgery are aging, and age‐related declines in physical function, particularly sarcopenia, also adversely affects outcomes.
Taku Fujimoto, Kie Uchikawa, Hiroshi Akasaka, Yukiko Yasunobe, Shino Yoshida, Yuri Onishi, Tomohiro Minami, Yuki Asada, Masaaki Isaka, Ken Sugimoto, Kotaro Yamashita, Norikatsu Miyoshi, Takehiro Noda, Hirofumi Akita, Mamoru Uemura, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hiroshi Koriyama, Koichi Yamamoto   +19 more
wiley   +1 more source

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir

, 2010
Alsu Gafurovna Zalevskaya, Залевская Алсу Гафуровна, N. I. Verbovaya, Вербовая Нэлли Ильинична, Т. И. Родионова   +4 more
openalex   +2 more sources

Long‐term remission of type B insulin resistance syndrome with immunotherapy: A case report

Journal of Diabetes Investigation, EarlyView.
ABSTRACT We report long‐term remission in a patient with type B insulin resistance achieved with a combination of immunotherapies. A 55‐year‐old Japanese man presented with nocturnal hypoglycemia and cytopenia. He also had postprandial hyperglycemia due to severe insulin resistance, which was difficult to manage using high‐dose insulin and recombinant ...
Erika Egawa, Rei Karasawa, Yuka Kageyama, Kazuhiko Takaya   +3 more
wiley   +1 more source

Studies in Potential Organo-fluorine Oral Hypoglycemic Agents. Part II. Synthesis of Some 1-Aryl-3-alkyl/aryl Sulphonylureas

, 1965
K. C. Joshi, Jharna Sen Gupta
openalex   +1 more source